![Frontiers | Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse Frontiers | Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse](https://www.frontiersin.org/files/Articles/581119/fimmu-11-581119-HTML/image_m/fimmu-11-581119-g001.jpg)
Frontiers | Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse
![Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842818301021-gr1.jpg)
Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect
![Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism in: Endocrine Connections Volume 7 Issue 5 (2018) Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism in: Endocrine Connections Volume 7 Issue 5 (2018)](https://ec.bioscientifica.com/view/journals/ec/7/5/images/EC-18-0079fig1.jpeg)
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism in: Endocrine Connections Volume 7 Issue 5 (2018)
![PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth.,Molecular Pharmaceutics - X-MOL PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth.,Molecular Pharmaceutics - X-MOL](https://xpic.x-mol.com/20191109%2F10.1021_acs.molpharmaceut.9b00826.jpg)
PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth.,Molecular Pharmaceutics - X-MOL
![Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma Guo JC, Tsai YC, Pu YS - Urol Sci Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma Guo JC, Tsai YC, Pu YS - Urol Sci](https://www.e-urol-sci.com/articles/2019/30/1/images/UrolSci_2019_30_1_2_249260_t3.jpg)
Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma Guo JC, Tsai YC, Pu YS - Urol Sci
![Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt-2018-0110/asset/images/medium/figure1.gif)
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
![Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy - Uricoli - 2021 - Advanced Healthcare Materials - Wiley Online Library Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy - Uricoli - 2021 - Advanced Healthcare Materials - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a7f1751b-480c-4f45-a623-6785fbd8053a/adhm202002214-fig-0001-m.jpg)
Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy - Uricoli - 2021 - Advanced Healthcare Materials - Wiley Online Library
![Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt-2018-0110/asset/images/medium/figure2.gif)
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
![Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's Disease | Anticancer Research Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's Disease | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/1/219/F3.large.jpg)
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's Disease | Anticancer Research
![Correlation between programmed cell death ligand 1 (PD-L1) and CD8 in... | Download Scientific Diagram Correlation between programmed cell death ligand 1 (PD-L1) and CD8 in... | Download Scientific Diagram](https://www.researchgate.net/publication/307576429/figure/fig1/AS:614036681027603@1523409161585/Correlation-between-programmed-cell-death-ligand-1-PD-L1-and-CD8-in-non-small-cell-lung.png)
Correlation between programmed cell death ligand 1 (PD-L1) and CD8 in... | Download Scientific Diagram
Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling
![Frontiers | Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer Frontiers | Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer](https://www.frontiersin.org/files/Articles/581301/fimmu-11-581301-HTML/image_m/fimmu-11-581301-g001.jpg)
Frontiers | Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer
![Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling](https://pubs.acs.org/cms/10.1021/acs.jcim.1c00301/asset/images/large/ci1c00301_0001.jpeg)
Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling
![Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy - Uricoli - 2021 - Advanced Healthcare Materials - Wiley Online Library Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy - Uricoli - 2021 - Advanced Healthcare Materials - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/294a0de3-f5c4-49ab-8239-a44ad0eca7b5/adhm202002214-fig-0002-m.jpg)
Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy - Uricoli - 2021 - Advanced Healthcare Materials - Wiley Online Library
![Viruses | Free Full-Text | The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications Viruses | Free Full-Text | The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications](https://www.mdpi.com/viruses/viruses-13-01346/article_deploy/html/images/viruses-13-01346-g001a.png)
Viruses | Free Full-Text | The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications
![PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. - Abstract - Europe PMC PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6349941/bin/41467_2019_8352_Fig1_HTML.jpg)
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. - Abstract - Europe PMC
Structural insights and binding analysis for determining the molecular bases for programmed cell death protein ligand-1 inhibition - MedChemComm (RSC Publishing)
![The programmed death ligand-1 (PD-L1) (B7-H1) pathway in regulation... | Download Scientific Diagram The programmed death ligand-1 (PD-L1) (B7-H1) pathway in regulation... | Download Scientific Diagram](https://www.researchgate.net/publication/319045267/figure/fig1/AS:614212506251275@1523451081927/The-programmed-death-ligand-1-PD-L1-B7-H1-pathway-in-regulation-of-T-cell-responses.png)
The programmed death ligand-1 (PD-L1) (B7-H1) pathway in regulation... | Download Scientific Diagram
![Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy | Scientific Reports Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-79419-3/MediaObjects/41598_2020_79419_Fig1_HTML.png)
Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy | Scientific Reports
![In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network - ScienceDirect In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021925820365923-gr1.jpg)